Legend Biotech (LEGN) Cash from Discontinued Operations (2023 - 2025)
Legend Biotech (LEGN) posted Cash from Discontinued Operations of 106286000.0 for Q1 2025, down 29.49% on a QoQ basis from 82078000.0 in Q4 2024, and down 4558.31% year-over-year from 2384000.0 in Q1 2024.
Legend Biotech (LEGN) Cash from Discontinued Operations (2023 - 2025) Analysis & Trends
Legend Biotech's Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 106286000.0 for Q1 2025.
- Quarterly Cash from Discontinued Operations fell 4558.31% year-over-year to 106286000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 281625000.0 (changed N/A YoY) and the FY2024 annual result came in at 144033000.0, up 63.38% from the prior year.
- Cash from Discontinued Operations was 106286000.0 for Q1 2025 at Legend Biotech, down from 82078000.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 2384000.0 in Q1 2024 and bottomed at 106286000.0 in Q1 2025.
- A 3-year average of 70406250.0 and a median of 88861500.0 in 2023 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2024 — Cash from Discontinued Operations rose 14.18% — and 2025, when it tumbled 4558.31%.
- Legend Biotech's Cash from Discontinued Operations stood at 95645000.0 in 2023, then grew by 14.18% to 82078000.0 in 2024, then slipped by 29.49% to 106286000.0 in 2025.
- Business Quant data shows LEGN's Cash from Discontinued Operations at 106286000.0 in Q1 2025, 82078000.0 in Q4 2024, and 2384000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -106.29 Mn |
| Mar 31, 2025 | -106.29 Mn |
| Dec 31, 2024 | -82.08 Mn |
| Dec 31, 2024 | -82.08 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Dec 31, 2023 | -95.65 Mn |